Quick Answer
Ultragenyx Pharmaceutical Inc. reported Total Assets of $1.53 billion for fiscal year 2025.
Ultragenyx Pharmaceutical Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.53B | +1.9% |
| 2024 | $1.50B | +0.8% |
| 2023 | $1.49B | -3.5% |
| 2022 | $1.55B | +1.5% |
| 2021 | $1.52B | -13.5% |
| 2020 | $1.76B | +55.0% |
| 2019 | $1.14B | +57.8% |
| 2018 | $719.56M | +46.6% |
| 2017 | $490.75M | -9.2% |
| 2016 | $540.63M | -3.4% |
| 2015 | $559.57M | +182.7% |
| 2014 | $197.97M | +231.9% |
| 2013 | $59.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.19B | -22.6% | -8.9% |
| June 30, 2025 | $1.31B | -19.3% | -0.4% |
| March 31, 2025 | $1.31B | +0.4% | -12.7% |
| December 31, 2024 | $1.50B | +0.8% | -2.3% |
| September 30, 2024 | $1.54B | +24.2% | -4.9% |
| June 30, 2024 | $1.62B | +23.4% | +23.8% |
| March 31, 2024 | $1.31B | -5.5% | -12.3% |
| December 31, 2023 | $1.49B | -3.5% | +20.4% |
- Ultragenyx Pharmaceutical Inc. showed an increase of +1.9% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Ultragenyx Pharmaceutical Inc.’s total assets has grown by 2468.4% (from $59.65 million to $1.53 billion).
- The most recent figure is from Ultragenyx Pharmaceutical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: